Cedar Mountain Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3
Closed -$1.12K – 1207
2026
Q2
$1.12K Hold
3
– – ﹤0.01% 932
2026
Q1
$775 Buy
+3
New +$798 ﹤0.01% 957

Other funds holding KRYS

Cedar Mountain Advisors's KRYS Position: Q3 2026 in Review

Cedar Mountain Advisors sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 3 shares — an estimated $1.12K sold.

Cedar Mountain Advisors first reported a position in KRYS in Q1 2026 and held it in 2 quarters. The position peaked at $1.12K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Cedar Mountain Advisors reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
  • Cedar Mountain Advisors sold 3 Krystal Biotech shares in Q3 2026, an estimated $1.12K.
  • Cedar Mountain Advisors first reported a position in Krystal Biotech in Q1 2026 and held it in 2 quarters.
  • Cedar Mountain Advisors's Krystal Biotech position peaked at $1.12K in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.